Hamin Lee , Jin-Wu Nam , Mi Kyung Kim , Inah Kim , Yu-Mi Kim , Boyoung Park
{"title":"Validation of self-reported cancer diagnoses in the Korean Atomic Bomb Survivor Cohort study","authors":"Hamin Lee , Jin-Wu Nam , Mi Kyung Kim , Inah Kim , Yu-Mi Kim , Boyoung Park","doi":"10.1016/j.canep.2025.102817","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Owing to the short history of the National Cancer Registry, self-reported cancer history is an important source of morbidity in recently constructed cohorts or cohorts of the older population. This study aimed to evaluate the validity of the self–reported cancer history gathered through the Korean Atomic Bomb Survivor Cohort (K-ABC) study compared with the Korean Central Cancer Registry (KCCR).</div></div><div><h3>Methods</h3><div>Among the K-ABC participants recruited from 2020 to 2024, self-reported cancer history from 1756 participants was linked to the KCCR. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and kappa coefficient were estimated for each cancer site.</div></div><div><h3>Results</h3><div>Among 181 participants with a minimum of one record in the KCCR, 164 reported a history of cancer. Overall cancers and each cancer site showed high sensitivity, PPV, and kappa values of > 80 %, > 66 %, and > 0.73, respectively, except for cervical and lung cancers, which showed sensitivities of < 50 % and kappa values of 0.33 and 0.59, respectively. High specificity and NPV (≥99 %) were observed for all cancer sites.</div></div><div><h3>Conclusions</h3><div>The validity of the self-reported cancer history of the K-ABC showed a relatively high level of agreement with the KCCR records. These findings indicate that self-reported cancer information from the K-ABC study is valid for all sexes and ages but needs consideration when used for evaluating cervical and lung cancer.</div></div>","PeriodicalId":56322,"journal":{"name":"Cancer Epidemiology","volume":"97 ","pages":"Article 102817"},"PeriodicalIF":2.4000,"publicationDate":"2025-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877782125000773","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Owing to the short history of the National Cancer Registry, self-reported cancer history is an important source of morbidity in recently constructed cohorts or cohorts of the older population. This study aimed to evaluate the validity of the self–reported cancer history gathered through the Korean Atomic Bomb Survivor Cohort (K-ABC) study compared with the Korean Central Cancer Registry (KCCR).
Methods
Among the K-ABC participants recruited from 2020 to 2024, self-reported cancer history from 1756 participants was linked to the KCCR. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and kappa coefficient were estimated for each cancer site.
Results
Among 181 participants with a minimum of one record in the KCCR, 164 reported a history of cancer. Overall cancers and each cancer site showed high sensitivity, PPV, and kappa values of > 80 %, > 66 %, and > 0.73, respectively, except for cervical and lung cancers, which showed sensitivities of < 50 % and kappa values of 0.33 and 0.59, respectively. High specificity and NPV (≥99 %) were observed for all cancer sites.
Conclusions
The validity of the self-reported cancer history of the K-ABC showed a relatively high level of agreement with the KCCR records. These findings indicate that self-reported cancer information from the K-ABC study is valid for all sexes and ages but needs consideration when used for evaluating cervical and lung cancer.
期刊介绍:
Cancer Epidemiology is dedicated to increasing understanding about cancer causes, prevention and control. The scope of the journal embraces all aspects of cancer epidemiology including:
• Descriptive epidemiology
• Studies of risk factors for disease initiation, development and prognosis
• Screening and early detection
• Prevention and control
• Methodological issues
The journal publishes original research articles (full length and short reports), systematic reviews and meta-analyses, editorials, commentaries and letters to the editor commenting on previously published research.